ALCHEMAB THERAPEUTICS LTD
Get an alert when ALCHEMAB THERAPEUTICS LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£45m
+186.3% vs 2024
Net assets
£23m
+348.9% vs 2024
Employees
55
-8.3% vs 2024
Profit before tax
£8.9m
+128.2% vs 2024
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £1,592,000 | £30,043,000 | +1,787.1% | |
| Operating profit | -£31,840,000 | £7,943,000 | +124.9% | |
| Profit before tax | -£31,345,000 | £8,851,000 | +128.2% | |
| Net profit | -£27,511,000 | £8,309,000 | +130.2% | |
| Cash | £15,584,000 | £44,612,000 | +186.3% | |
| Total assets less current liabilities | £4,356,000 | £50,084,000 | +1,049.8% | |
| Net assets | -£9,339,000 | £23,246,000 | +348.9% | |
| Equity | -£9,339,000 | £23,246,000 | +348.9% | |
| Average employees | 60 | 55 | -8.3% | |
| Wages | £6,153,000 | £4,709,000 | -23.5% | |
| Directors' remuneration | £1,077,000 | £687,000 | -36.2% | |
| Directors' pension contributions | £26,000 | £32,000 | +23.1% | |
| Highest paid director | £666,000 | £635,000 | -4.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating margin | — | 26.4% | |
| Net margin | — | 27.7% | |
| Return on capital employed | -730.9% | 15.9% | |
| Gearing (liabilities / total assets) | 141.6% | 58.2% | |
| Current ratio | 1.13x | 9.76x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe the Group has adequate cash positions and controls over future cashflow to allow the Group to continue for at least 12 months from the approval of the financial statements.”
Group structure
- ALCHEMAB THERAPEUTICS LTD · parent
- Alchemab, Inc 100%
Significant events
- “In June 2026, the Company raised £25,000,000 in new funding through the issue of equity.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 8 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GATES, Malcolm Derek | Secretary | 2026-03-05 | — | — |
| BINGHAM, Catherine Elizabeth, Dame | Director | 2023-07-26 | Oct 1965 | British |
| CIRCELLI, Carmine Daniel, Dr. | Director | 2026-06-17 | Mar 1986 | British |
| HEBERT, Jenna | Director | 2026-05-28 | Mar 1994 | American |
| LEE, Kevin | Director | 2021-06-30 | Apr 1968 | English |
| MAY, Andrew Paul, Dr | Director | 2026-06-04 | Apr 1973 | British |
| OSBOURN, Jane Katharine | Director | 2024-09-11 | Mar 1966 | British |
Show 8 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ASHRAFIAN, Houman, Professor | Director | 2021-04-13 | 2023-07-26 |
| COSTINE, James Allister John | Director | 2019-08-14 | 2021-04-13 |
| DINES, Jonathon Alan | Director | 2019-08-14 | 2020-04-09 |
| HAMER, John | Director | 2021-04-13 | 2026-06-04 |
| KWON, Young T., Mr. | Director | 2022-05-25 | 2024-09-11 |
| LEECH, Alexander Robert | Director | 2019-08-14 | 2021-04-13 |
| LEVIN, Andrew David | Director | 2021-04-13 | 2026-05-21 |
| TRECO, Douglas, Dr | Director | 2021-04-13 | 2022-04-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Sv7 (Imf) Gp Llp | Corporate entity | Shares 25–50% (as firm), Voting 25–50% (as firm) | 2019-08-14 | Ceased 2021-04-13 |
| Dementia Discovery Gp Lp | Corporate entity | Shares 25–50%, Voting 25–50% | 2019-08-14 | Ceased 2020-04-02 |
Filing timeline
Last 20 of 92 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-07-07 MA Memorandum articles
- 2026-07-07 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-30 | AA | accounts | Accounts with accounts type group | |
| 2026-07-14 | SH01 | capital | Capital allotment shares | |
| 2026-07-14 | SH01 | capital | Capital allotment shares | |
| 2026-07-07 | MA | incorporation | Memorandum articles | |
| 2026-07-07 | RESOLUTIONS | resolution | Resolution | |
| 2026-07-01 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-23 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-19 | AP01 | officers | Appoint person director company with name date | |
| 2026-06-19 | TM01 | officers | Termination director company with name termination date | |
| 2026-06-19 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-10 | CH03 | officers | Change person secretary company with change date | |
| 2026-03-10 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-12-12 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-11-20 | SH01 | capital | Capital allotment shares | |
| 2025-10-22 | SH01 | capital | Capital allotment shares | |
| 2025-10-02 | AA | accounts | Accounts with accounts type medium | |
| 2025-08-28 | SH01 | capital | Capital allotment shares | |
| 2025-07-31 | SH01 | capital | Capital allotment shares | |
| 2025-07-28 | SH08 | capital | Capital name of class of shares | |
| 2025-07-28 | SH10 | capital | Capital variation of rights attached to shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 16
- Capital events
- 8
- Officers appointed
- 4
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.